VENDOR COMPARISON

Paradigm Peptide vs Shanghai JinBei Chemical

Independent side-by-side comparison across the 1 peptides both vendors sell. Composite scores, lab quality, and verified pricing.

Paradigm Peptide

Research
B+
Score
7.4
Peptides
6
Tests
54

Top Retatrutide vendor by score (9.0 across 14 tests). Strong on metabolic peptides.

Paradigm Peptide full review →

Shanghai JinBei Chemical

Manufacturer
B
Score
7.0
Peptides
3
Tests
28

Manufacturer with focus on Tirzepatide. 9 tests averaging 8.6/10. Less Western community sentiment.

Shanghai JinBei Chemical full review →

Side-by-side breakdown

PEPTIDE PARADIGM PEPTIDE SHANGHAI JINBEI CHEMICAL WINNER
Ipamorelin
9.0 A (6 tests)
(not sold)
Paradigm Peptide only
Tirzepatide
8.4 B+ (14 tests)
8.6 B+ (9 tests)
Shanghai JinBei Chemical
Retatrutide
7.0 B (14 tests)
(not sold)
Paradigm Peptide only
Semaglutide
(not sold)
7.5 B (8 tests)
Shanghai JinBei Chemical only

Which to choose

Across the 1 peptides both vendors sell, Paradigm Peptide scores higher on 0, Shanghai JinBei Chemical scores higher on 0, and 1 are within 0.3 points (effectively tied). Shanghai JinBei Chemical additionally sells Semaglutide; Paradigm Peptide does not. Paradigm Peptide additionally sells Ipamorelin, Retatrutide; Shanghai JinBei Chemical does not.

Either works for Tirzepatide — composite scores are within 0.3 points.

Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.

Full profiles: Paradigm Peptide review · Shanghai JinBei Chemical review